Journal of Clinical Endocrinology & Metabolism, Vol 78, 418-422, Copyright © 1994 by Endocrine Society

ARTICLES

A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome

HL Dichek, LK Nieman, EH Oldfield, HI Pass, JD Malley and GB Cutler Jr
Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.

To improve the overnight 8-mg dexamethasone (DEX) suppression test (DST) for differential diagnosis of Cushing's syndrome and to develop optimal criteria for its interpretation, we increased the number of blood samples and measured the suppression of both plasma ACTH and cortisol. Forty-one patients who were subsequently proven at surgery to have Cushing's syndrome were studied (34 Cushing's disease and 7 ectopic ACTH secretion). DEX (8 mg, orally) was administered at 2300 h. Blood samples for ACTH and cortisol measurements were obtained at 0800, 0830, and 0900 h on the day before and at 0700, 0800, 0900, and 1000 h on the morning after DEX treatment. The conventional 6-day DST was also performed, with measurement of both urinary free cortisol and urinary 17-hydroxysteroids as indices of suppression. Optimal criteria for the diagnosis of Cushing's disease were developed for both the overnight 8- mg and the 6-day tests using receiver operating characteristic curves. The results were compared with those using the previously published criteria for diagnosis of Cushing's disease by the overnight 8-mg test (> 50% suppression of plasma cortisol at 0700-0800 h). In our patients, the previously published criterion for the overnight 8-mg test yielded high sensitivity (88%), but low specificity (57%), in making the diagnosis of Cushing's disease. When the time of cortisol measurement and the diagnostic criteria for Cushing's disease were revised to achieve 100% specificity, the sensitivity of the overnight 8-mg test was 71%, which was not significantly different from that of the 6-day test (79%; P = NS). Addition of plasma ACTH levels to the test did not improve diagnostic accuracy compared to that with measurement of plasma cortisol levels alone. When the revised 8-mg overnight dexamethasone suppression test was combined with the 6-day dexamethasone suppression test, sensitivity increased to 91%, with a specificity of 100%, which was significantly better than that of the overnight 8-mg test alone (P < 0.002). We conclude that the overnight 8-mg DST has low specificity for the diagnosis of Cushing's disease when performed as originally described. However, with revised sampling times and diagnostic criteria, the overnight test has sensitivity and specificity similar to those of the conventional 6-day DST. The diagnostic performance of a criterion that combines the results of both tests is better than the diagnostic performance of either test alone.

This article has been cited by other articles:

				D. L. Batista, J. Riar, M. Keil, and C. A. Stratakis Diagnostic Tests for Children Who Are Referred for the Investigation of Cushing Syndrome Pediatrics, September 1, 2007; 120(3): e575 - e586. [Abstract] [Full Text] [PDF]

				R M Testa, N Albiger, G Occhi, F Sanguin, M Scanarini, S Berlucchi, M P Gardiman, C Carollo, F Mantero, and C Scaroni The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging Eur. J. Endocrinol., February 1, 2007; 156(2): 241 - 248. [Abstract] [Full Text] [PDF]

				I. Ilias, D. J. Torpy, K. Pacak, N. Mullen, R. A. Wesley, and L. K. Nieman Cushing's Syndrome Due to Ectopic Corticotropin Secretion: Twenty Years' Experience at the National Institutes of Health J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4955 - 4962. [Abstract] [Full Text] [PDF]

				J. R. Lindsay, J. Jonklaas, E. H. Oldfield, and L. K. Nieman Cushing's Syndrome during Pregnancy: Personal Experience and Review of the Literature J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3077 - 3083. [Abstract] [Full Text] [PDF]

				I. Ilias, R. Chang, K. Pacak, E. H. Oldfield, R. Wesley, J. Doppman, and L. K. Nieman Jugular Venous Sampling: An Alternative to Petrosal Sinus Sampling for the Diagnostic Evaluation of Adrenocorticotropic Hormone-Dependent Cushing's Syndrome J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3795 - 3800. [Abstract] [Full Text] [PDF]

				K. Pacak, I. Ilias, C. C. Chen, J. A. Carrasquillo, M. Whatley, and L. K. Nieman The Role of [18F]Fluorodeoxyglucose Positron Emission Tomography and [111In]-Diethylenetriaminepentaacetate-D-Phe-Pentetreotide Scintigraphy in the Localization of Ectopic Adrenocorticotropin-Secreting Tumors Causing Cushing's Syndrome J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2214 - 2221. [Abstract] [Full Text] [PDF]

				A. M. Isidori, G. A. Kaltsas, S. Mohammed, D. G. Morris, P. Jenkins, S. L. Chew, J. P. Monson, G. M. Besser, and A. B. Grossman Discriminatory Value of the Low-Dose Dexamethasone Suppression Test in Establishing the Diagnosis and Differential Diagnosis of Cushing's Syndrome J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5299 - 5306. [Abstract] [Full Text] [PDF]

				P. Loli, F. Vignati, E. Grossrubatscher, P. Dalino, M. Possa, F. Zurleni, G. Lomuscio, O. Rossetti, M. Ravini, A. Vanzulli, et al. Management of Occult Adrenocorticotropin-Secreting Bronchial Carcinoids: Limits of Endocrine Testing and Imaging Techniques J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1029 - 1035. [Abstract] [Full Text] [PDF]

				M. Boscaro, L. Barzon, and N. Sonino The Diagnosis of Cushing's Syndrome: Atypical Presentations and Laboratory Shortcomings Arch Intern Med, November 13, 2000; 160(20): 3045 - 3053. [Abstract] [Full Text] [PDF]

				M. I. Wiggam, A. P. Heaney, E. M. McIlrath, D. R. McCance, B. Sheridan, D. R. Hadden, and A. B. Atkinson Bilateral Inferior Petrosal Sinus Sampling in the Differential Diagnosis of Adrenocorticotropin-Dependent Cushing's Syndrome: A Comparison with Other Diagnostic Tests J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1525 - 1532. [Abstract] [Full Text]

				N. J. Sarlis, S. J. Chanock, and L. K. Nieman Cortisolemic Indices Predict Severe Infections in Cushing Syndrome Due to Ectopic Production of Adrenocorticotropin J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 42 - 47. [Abstract] [Full Text]

				R. M. Pluta, L. Nieman, J. L. Doppman, J. C. Watson, N. Tresser, D. A. Katz, and E. H. Oldfield Extrapituitary Parasellar Microadenoma in Cushing's Disease J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2912 - 2923. [Abstract] [Full Text]

				K. E. Graham, M. H. Samuels, G. M. Nesbit, D. M. Cook, O. R. O’Neill, S. L. Barnwell, and D. L. Loriaux Cavernous Sinus Sampling Is Highly Accurate in Distinguishing Cushing's Disease from the Ectopic Adrenocorticotropin Syndrome and in Predicting Intrapituitary Tumor Location J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1602 - 1610. [Abstract] [Full Text]

				D. J. TORPY, C. C. CHEN, N. MULLEN, J. L. DOPPMAN, J. A. CARRASQUILLO, G. P. CHROUSOS, and L. K. NIEMAN Lack of Utility of 111In-Pentetreotide Scintigraphy in Localizing Ectopic ACTH Producing Tumors: Follow-Up of 18 Patients J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1186 - 1192. [Abstract] [Full Text]

				C. Invitti, F. P. Giraldi, M. De Martin, and F. Cavagnini Diagnosis and Management of Cushing's Syndrome: Results of an Italian Multicentre Study J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 440 - 448. [Abstract] [Full Text]

				J. L. Doppman, R. Chang, E. H. Oldfield, G. Chrousos, C. A. Stratakis, and L. K. Nieman The Hypoplastic Inferior Petrosal Sinus: A Potential Source of False-Negative Results in Petrosal Sampling for Cushing's Disease J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 533 - 540. [Abstract] [Full Text]

				J. Newell-Price, P. Trainer, M. Besser, and A. Grossman The Diagnosis and Differential Diagnosis of Cushing's Syndrome and Pseudo-Cushing's States Endocr. Rev., October 1, 1998; 19(5): 647 - 672. [Abstract] [Full Text]

				J. A. Yanovski, G. B. Cutler Jr., G. P. Chrousos, and L. K. Nieman The Dexamethasone-Suppressed Corticotropin-Releasing Hormone Stimulation Test Differentiates Mild Cushing's Disease from Normal Physiology J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 348 - 352. [Abstract] [Full Text]

				D. C. Aron, H. Raff, and J. W. Findling Effectiveness Versus Efficacy: The Limited Value in Clinical Practice of High Dose Dexamethasone Suppression Testing in the Differential Diagnosis of Adrenocorticotropin-Dependent Cushing's Syndrome J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1780 - 1785. [Abstract] [Full Text] [PDF]

				D. N. Orth Cushing's Syndrome N. Engl. J. Med., March 23, 1995; 332(12): 791 - 803. [Full Text] [PDF]